Billie Lawler
Acute Care · Mount Pleasant, WINPI 1245253764
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AstraZeneca at 37.4% of the total. Reporting peaked in 2023 at $1,364 and has fallen 55.1% since, to $613 in 2025. Among acute care clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $33.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$527
- Novo Nordisk$468
- GSK$270
- Boehringer Ingelheim$260
- Biohaven Pharmaceuticals, Inc.$213
- plus $1K from 23 others
What the payments were for
- Food & beverage$5,04098%
- Education$1142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $1,928 |
| AbbVie | 21 | $527 |
| Novo Nordisk | 21 | $468 |
| GSK | 5 | $270 |
| Boehringer Ingelheim | 7 | $260 |
| Biohaven Pharmaceuticals, Inc. | 3 | $213 |
| Aimmune Therapeutics, Inc. | 3 | $178 |
| Lundbeck LLC | 3 | $151 |
| Dexcom, Inc. | 1 | $123 |
| Johnson & Johnson | 6 | $115 |
| Pfizer | 4 | $98 |
| E.r. Squibb & Sons, L.L.C. | 6 | $90 |
| Kestra Medical Technology Services, Inc. | 5 | $90 |
| Amgen | 5 | $87 |
| Heartflow, Inc. | 5 | $87 |
| Lilly USA, LLC | 5 | $77 |
| Novartis | 3 | $69 |
| Mylan Specialty L.p. | 3 | $58 |
| Merck | 3 | $49 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| IBSA Pharma Inc. | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| CSL Behring | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,154 in reported general payments places this provider in the 95th percentile of 127 acute care providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $19,509 |
| ClopidogrelClopidogrel Bisulfate | 26 | $358 |
| Isosorbide Dinitrate | 12 | $344 |
| Amlodipine Besylate | 24 | $243 |
| Atorvastatin Calcium | 23 | $239 |
| Methylprednisolone | 19 | $135 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $132 |
| Fluticasone Propionate | 11 | $123 |
| Hydrochlorothiazide | 12 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $53 |
| Azithromycin | 25 | $51 |
| Metoprolol Tartrate | 18 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $98 | $19,50965 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 127 acute care providers in Wisconsin.
Other acute care in Mount Pleasant
- Kelsey CramerMilwaukee$5K
- Elizabeth LaufenbergMilwaukee$5K
- Joel SchaeveBrookfield$4K
- Avery LebowitzMenasha$4K
- Deborah SauerWausau$4K
- Evgeniya KhenOconomowoc$2K
- Julie PruettMilwaukee$2K
- Craig SchuttaMilwaukee$2K
- Kayla DavisWaukesha$2K
- Lee KlemensMilwaukee$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.